NCT04567316View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

January 10, 2021

Study Completion Date

January 10, 2021

Conditions
Healthy
Interventions
DRUG

[14C]-radiolabelled BI 1358894

Part 1

DRUG

BI 1358894

Part 2

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04567316 - A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the Body | Biotech Hunter | Biotech Hunter